Joseph Catanzaro

Stock Analyst at Mizuho

(3.88)
# 629
Out of 5,149 analysts
105
Total ratings
46.51%
Success rate
12.23%
Average return

Stocks Rated by Joseph Catanzaro

Eikon Therapeutics
Mar 2, 2026
Initiates: Outperform
Price Target: $26
Current: $14.01
Upside: +85.65%
Tango Therapeutics
Feb 23, 2026
Initiates: Outperform
Price Target: $19
Current: $11.37
Upside: +67.11%
Nurix Therapeutics
Jan 29, 2026
Maintains: Overweight
Price Target: $32$35
Current: $15.22
Upside: +129.96%
ImmunityBio
Jan 20, 2026
Maintains: Overweight
Price Target: $5$7
Current: $10.16
Upside: -31.10%
CytomX Therapeutics
Jan 20, 2026
Maintains: Overweight
Price Target: $6.5$10
Current: $5.11
Upside: +95.69%
Revolution Medicines
Jan 13, 2026
Maintains: Outperform
Price Target: $90$143
Current: $100.28
Upside: +42.60%
Avalo Therapeutics
Dec 18, 2025
Initiates: Outperform
Price Target: $39
Current: $17.18
Upside: +127.01%
Upstream Bio
Dec 18, 2025
Initiates: Outperform
Price Target: $51
Current: $7.41
Upside: +588.26%
Bicara Therapeutics
Dec 18, 2025
Initiates: Neutral
Price Target: $18
Current: $17.42
Upside: +3.33%
Spyre Therapeutics
Dec 18, 2025
Initiates: Outperform
Price Target: $53
Current: $40.51
Upside: +30.83%
Maintains: Outperform
Price Target: $81$120
Current: $87.49
Upside: +37.16%
Initiates: Outperform
Price Target: $48
Current: $29.14
Upside: +64.72%
Initiates: Outperform
Price Target: $105
Current: $67.15
Upside: +56.37%
Maintains: Neutral
Price Target: $7.5$6
Current: $3.77
Upside: +59.36%
Maintains: Overweight
Price Target: $50$45
Current: $11.85
Upside: +279.75%
Maintains: Overweight
Price Target: $105$110
Current: $146.33
Upside: -24.83%
Maintains: Overweight
Price Target: $37$38
Current: $40.79
Upside: -6.84%
Maintains: Overweight
Price Target: $40$15
Current: $13.57
Upside: +10.54%
Maintains: Neutral
Price Target: $52$53
Current: $69.07
Upside: -23.27%
Maintains: Overweight
Price Target: $7$10
Current: $1.87
Upside: +436.19%
Maintains: Overweight
Price Target: $10$19
Current: $1.29
Upside: +1,372.87%
Initiates: Overweight
Price Target: $19
Current: $9.60
Upside: +97.92%
Maintains: Overweight
Price Target: $12$15
Current: $2.33
Upside: +545.16%
Maintains: Overweight
Price Target: $36
Current: $12.75
Upside: +182.35%
Maintains: Overweight
Price Target: $40
Current: $10.30
Upside: +288.54%
Maintains: Overweight
Price Target: $15
Current: $10.83
Upside: +38.50%
Initiates: Overweight
Price Target: $4.5
Current: $2.23
Upside: +101.79%
Maintains: Overweight
Price Target: $26$30
Current: $1.58
Upside: +1,798.73%
Initiates: Overweight
Price Target: $20
Current: $1.14
Upside: +1,662.11%
Downgrades: Neutral
Price Target: $15$1.75
Current: $2.67
Upside: -34.46%
Maintains: Overweight
Price Target: $18$20
Current: $23.95
Upside: -16.49%
Downgrades: Neutral
Price Target: $25$1.5
Current: $2.55
Upside: -41.18%
Maintains: Overweight
Price Target: $240$200
Current: $28.59
Upside: +599.55%
Initiates: Overweight
Price Target: $35
Current: $17.00
Upside: +105.88%
Initiates: Overweight
Price Target: $60
Current: $1.34
Upside: +4,377.61%
Maintains: Overweight
Price Target: $28$18
Current: $2.31
Upside: +679.22%